Back

Plasma levels of sCASP3 predicts carotid intima media thickness progression

2 September 2024 (15:00 - 15:40)
Organised by: Logo
Congress Presentation Part of: Carotid plaque: epidemiology and evolution Carotid Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Mengyu Pan

Lund University, Malmo (Sweden)

6 More presentations in this session

Presentation thumbnail
Plasma cytokines are associated with major adverse cardiovascular events in follow-up of patients undergoing carotid endarterectomy
Doctor V. Nardi (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Adverse outcomes following carotid artery stenting in echolucent plaques: a systematic review and meta-analysis
Associate Professor P. Ibrahimi (Pristina, XK)
Abstract Slides Video
Presentation thumbnail
Mortality risk in patients with carotid artery disease undergoing carotid endarterectomy compared to the general population
Doctor L. Di Venanzio (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Minimal extra-cardiac atherosclerosis in people <50 years with sudden cardiac death due to coronary disease
Doctor E. Paratz (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Effect of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on carotid intima-media thickness
Doctor K. Katogiannis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Carotid plaque: epidemiology and evolution

The Event

Event poster

ESC Congress 2024

2 September 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Carotid intima-media thickness stratifies early and supernormal vascular aging phenotypes in the UK Biobank: implications for cardiovascular risk prediction
thumbnail
Congress Presentation
Association between neutrophil count, LDL-C, and long-term carotid plaque progression
thumbnail
Congress Presentation
Investigating lifestyle determinants of carotid intima-media thickness: cross-sectional insights from the UK biobank cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources